Foxo Technologies Inc. (FOXO)
AMEX AMEX Primary Summary
FOXO Chart
Why Is Foxo Technologies (FOXO) Stock Up 55% Today?
Foxo Technologies (NYSEMKT: FOXO ) stock is up on Friday after the epigenetic biomarkers technology company announced two acquisition deals. The first deal announced by Foxo Technologies is with Myrtle Recovery Centers.
Foxo Technologies Inc. Dividends
Foxo Technologies Inc. Earnings
| 18 Aug 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
| 26 Jun 2025 Date | | - Cons. EPS | - EPS |
| 17 Jan 2025 Date | | - Cons. EPS | - EPS |
| 19 Aug 2024 Date | | - Cons. EPS | - EPS |
| 14 Aug 2024 Date | | - Cons. EPS | - EPS |
| 18 Aug 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
| 26 Jun 2025 Date | | - Cons. EPS | - EPS |
| 17 Jan 2025 Date | | - Cons. EPS | - EPS |
| 19 Aug 2024 Date | | - Cons. EPS | - EPS |
| 14 Aug 2024 Date | | - Cons. EPS | - EPS |
Foxo Technologies Inc. (FOXO) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Foxo Technologies Inc. ever had a stock split?
Foxo Technologies Inc. Profile
| Medical - Healthcare Information Services Industry | Healthcare Sector | Seamus Lagan CEO | AMEX Exchange | 351471305 Cusip |
| US Country | 102 Employees | - Last Dividend | 28 Jul 2025 Last Split | 29 Jan 2021 IPO Date |
Overview
FOXO Technologies Inc. is an innovative company that operates in the field of epigenetic biomarker underwriting technology and consumer engagement platform service within the United States. Founded in 2020 and headquartered in Minneapolis, Minnesota, FOXO Technologies has developed a unique approach by applying automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers associated with human health, wellness, and aging. The company operates through two main segments, FOXO Labs and FOXO Life, focusing on developing cutting-edge solutions for the life insurance industry and beyond. As a subsidiary of FOXO Management LLC, FOXO Technologies Inc. aims to revolutionize the way biomarker solutions are utilized for underwriting and risk assessment in the insurance sector.
Products and Services
- FOXO Labs
FOXO Labs is at the forefront of commercializing proprietary epigenetic biomarker technology. This segment focuses on enabling the adoption of saliva-based health and wellness biomarker solutions, which are designed to revolutionize underwriting and risk assessment processes. By leveraging the latest advances in automatic machine learning and artificial intelligence, FOXO Labs aims to provide the insurance industry with innovative tools for assessing policyholder risk based on reliable biomarkers related to health, wellness, and aging.
- FOXO Life
FOXO Life represents the company’s sales and distribution platform, which is primarily focused on recruiting independent life insurance agents. These agents are tasked with selling life insurance policies bundled with the Longevity Report. The Longevity Report, a unique feature of FOXO Life products, offers policyholders insights into their health and aging biomarkers, offering a new dimension to traditional life insurance. Through this platform, FOXO Technologies aims to not only enhance the way life insurance is sold but also to encourage a broader conversation around longevity and wellness.
Contact Information
